Detalhe da pesquisa
1.
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.
Cytotherapy
; 22(7): 388-397, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414635
2.
Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children.
Pediatr Transplant
; 22(2)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388302
3.
Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.
Br J Haematol
; 167(3): 402-10, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066775
4.
The protozoan parasite, Theileria annulata, induces a distinct acute phase protein response in cattle that is associated with pathology.
Int J Parasitol
; 33(12): 1409-18, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14527523
5.
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.
Blood
; 110(4): 1123-31, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17468341
6.
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.
J Immunother
; 27(4): 309-16, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15235392
7.
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.
Lancet
; 360(9331): 436-42, 2002 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12241714